Dies ist eine Übersichtsseite mit Metadaten zu dieser wissenschaftlichen Arbeit. Der vollständige Artikel ist beim Verlag verfügbar.
Bridging laboratory science and clinical practice: the impact of emerging biomarkers. Highlights from the artificial intelligence in the Clinical Laboratory Session at the 56th SIBioC Congress, 2024
0
Zitationen
5
Autoren
2025
Jahr
Abstract
Circulating biomarkers are a fundamental tool that offers numerous advantages compared to other diagnostic tools, such as radiological ones, not least the relatively low cost. Thanks to studies evaluating their efficiency and effectiveness, new biomarkers have found space in routine clinical practice in recent years. The implementation of new biomarkers in clinical practice has the potential to revolutionize patient diagnosis, prognosis, and treatment strategies. This collective paper, based on discussions from the 56th SIBioC Congress (Bologna, October 2024), provides an overview of key emerging circulating biomarkers, their analytical performance, and their impact on clinical decision-making. Adopting new biomarkers in clinical settings can enhance diagnostic accuracy, reduce healthcare costs, and improve patient care.
Ähnliche Arbeiten
Explainable Artificial Intelligence (XAI): Concepts, taxonomies, opportunities and challenges toward responsible AI
2019 · 8.245 Zit.
Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead
2019 · 8.102 Zit.
High-performance medicine: the convergence of human and artificial intelligence
2018 · 7.468 Zit.
Proceedings of the 19th International Joint Conference on Artificial Intelligence
2005 · 5.776 Zit.
Peeking Inside the Black-Box: A Survey on Explainable Artificial Intelligence (XAI)
2018 · 5.429 Zit.